Interpreting the Regulatory Perspective on Adaptive Designs

   

 By John Balser, PhD, Mark Chang, PhD, and Robin Bliss, PhD

In 2010, the FDA published a draft guidance on how to conduct an adaptive designs clinical trial. In 2016, a final guidance was published on a similar topic, while also emphasizing the FDA's support for using adaptive designs for clinical trials. Download the compelling article by Veristat's top statistical experts to understand the advantages of adaptive designs and how it can help increase the chances for the success of a clinical trial.